Risk of nonmelanoma skin cancer with azathioprine use.

@article{Maddox2008RiskON,
  title={Risk of nonmelanoma skin cancer with azathioprine use.},
  author={Jessica S Maddox and Keyoumars Soltani},
  journal={Inflammatory bowel diseases},
  year={2008},
  volume={14 10},
  pages={
          1425-31
        }
}
While often life-saving for many complex diseases, iatrogenic immunosuppression has been associated with life-threatening infections and malignancies. Among these malignancies is skin cancer. Skin cancer is the most common form of cancer in the United States; the nonmelanoma skin cancers have an annual incidence of greater than 1,000,000 people in the US. It is well documented that the risk of nonmelanoma skin cancer (NMSC) is increased in those who are immunosuppressed. While many articles… CONTINUE READING